Hetero has been committed towards HIV/AIDS treatment since 1997 and today it is recognized as one of the global leaders for producing and supplying affordable ARV APIs and Formulations. Having a wide portfolio of over 30 ARV combinations, our products are currently spreading hope in the lives of 4.5 million* HIV/AIDS patients globally.
Buoyed by a dedicated R & D and expansive manufacturing facilities, we are able to consistently expand our capabilities to meet the growing demand for ARV medicines. Our commitment to the cause has seen us emerge as a partner of choice for renowned global procurement agencies.
*One in every three HIV/AIDS patients in the world trusts Hetero’s ARV medicines.*Yr.2015/16, Either API or FDF, Data on file